Clinical Indication

Children growth hormone deficiency; Burns; Adult growth hormone deficiency

Highlights

Dominant brand of rhGH in China with 70% of market share;

The 1st rhGH approval to treat burns in the world;

Complete clinical trials study Phase I II III;

PIC/S GMP and Colombia GMP available.

Specification 

Liquid: 

15 IU/5mg/ 3ml/ cartridge, 

30 IU/ 10mg/ 3ml/ cartridge, 

with special pen

Powder: 4,10,12 IU/vial

Administration 

Once per day

Dosage Form

Liquid or lyophilized powder